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Methods: Participants in the Dialysis Access Consor-
tium trial with upper extremity prosthetic grafts of the
brachial artery were studied. Multivariable analyses adjust-
ing for treatment group, center, gender, race, BMI, dia-
betes, current dialysis, and prior access or catheter were
performed to compare outcomes of forearm (fAVG) and
upper arm (uAVG) grafts including loss of primary unas-
sisted patency (LPUP) and cumulative primary graft failure
(CGF). Subgroup analyses of graft conﬁguration and
outﬂow vein used were conducted.
Results: Of the 522 participants with an upper
extremity brachial artery graft, 269 had fAVG and 253 had
uAVG. Participants with fAVG were less often male (33%
vs 43%; P ¼ .03), black (62% vs 77%; P < .001), dialysis-
dependent at time of surgery (20% vs 36%; P < .001), and
had a higher mean BMI (32 vs 29; P < .001) compared to
those with uAVG. There was no difference in LPUP (69%
vs 78%; P ¼ .22) or CGF (32% vs 36%; P ¼ .53) between
fAVG and uAVG at 1 year follow-up. Multivariable adjust-
ment did not change the statistical signiﬁcance of the associ-
ation between AVG location and either LPUP (HR, 1.26;
95% CI, 0.98, 1.62; P ¼ .07) or CGF (HR, 1.09; 95% CI,
0.80, 1.49; P ¼ .58). LPUP did not differ signiﬁcantly
between fAVG and uAVG among subgroups based on
AVGconﬁguration (P¼ .23) or outﬂow vein used (P¼ .53).
Conclusions: Patency of fAVG and uAVG was similar
despite the larger caliber veins often encountered in the
upper arm. Therefore, to preserve a maximal number of
access sites, the forearm location should be considered ﬁrst
before resorting to an upper arm graft.
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Reconstruction of the Greater Saphenous Vein to
Create a Viable Arterio-Venous Fistula Conduit
Faris Alomran, Benoit Boura, Alexandros Mallios, Romain
De Blic, Alessandro Costanzo, Myriam Combes. IMM,
Paris, France
Background: Vascular surgeons are sometimes faced
with central vein occlusions and other situations where
upper limb ﬁstulas are not viable. In the lower limb pros-
thetic grafts have been the mainstay conduit for dialysis
access with high rates of occlusion and infection. Some
authors have published data on the use of the femoral
superﬁcial vein however this is a long complex procedure
with signiﬁcant disruption of the lower limb venous return.
The greater saphenous vein (GSV) has proved previously to
be a poor conduit due to its resistance to dilatation and
only few reports have mentioned its effective use in dialysis.
The technique exhibited in this video results in
a doubled diameter of the GSV allowing easy puncture
and effective dialysis. It has all the advantages of anautologous conduit without the morbidity associated
with the superﬁcial femoral vein graft.
We also believe that this technique can be used in other
locations such as the upper limb in selected patients not
candidates for prosthetic grafts.
Technical Description: After harvesting the required
length of the GSV, it is opened longitudinally upto approx-
imately 5 cm from the sapheno-femoral junction (but not
sectioned vertically to avoid the requirement for a veno-
venous anastomosis). The GSV is freed from all valves
and then folded in two creating one anterior and one
posterior vein panel.
The lateral edges of the panels are sutured together,
and the medial edges together effectively creating
a cylinder, whilst doubling the initial GSV diameter. After
venous testing the vein is tunnelled subcutaneously and
down to the superﬁcial femoral artery (SFA). The size of
the anastomosis is tailored to avoid lower limb steal
syndrome. The vein is anastomosed to the SFA.
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Objectives: Retrievable IVC ﬁlters are appealing
because they are designed for either retrieval or long
term use. However, their long-term safety compared to
permanent ﬁlters is largely unknown. This study was under-
taken to compare complication rates and types associated
with retrievable and permanent ﬁlters.
Methods: A retrospective review identiﬁed 1231 IVC
ﬁlters (447 retrievable, 784 permanent) placed in 1227
patients from 2005-2010. Patients with retrievable ﬁlters
removed electively were excluded, yielding 382 patients
(group A) in whom retrievable ﬁlters were left in place.
These patients were compared to those with permanent
ﬁlters (group B) with respect to demographics, comorbid-
ities, survival, and complication rate and type. Differences
in patient characteristics were tested with c2, Fisher exact,
and Wilcox rank-sum tests. Logistic regression was used to
identify predictors of complications.
Results: Group A patients were younger than those in
group B (mean age, 64 vs 75; P < .0001). Group A had
signiﬁcantly more complications than group B (9.7% vs
1.9%; P < .0001) after mean follow up of 20 months
(range 0-86 mo). Furthermore, retrievable ﬁlter type was
a signiﬁcant predictor of complications in a multivariate
model (odds ratio, 5.4; P < .0001). Filter complications
were categorized as thrombotic, device related, or systemic.
While the most common complication type with retriev-
able ﬁlters was device related (52%) and with permanent
ﬁlters was thrombotic (63%), both thrombotic and device
related complications occurred more frequently in group
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related, 5% vs 0.5%; P < .0001).
Conclusions: Indwelling retrievable IVC ﬁlters were
associated with signiﬁcantly higher complication rates
than permanent ﬁlters. Both thrombotic and device related
complications were more common with retrievable ﬁlters.
Long term use of retrievable ﬁlters should be avoided,
especially considering the younger population in whom
they are placed.
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Venous Ulceration and Perforator Sclerotherapy:
Successful Injection Predicts Healing
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Objectives: Describe and quantify the effects of perfo-
rator sclerotherapy on venous ulcers (CEAP 6) without
axial reﬂux
Methods: Retrospective analysis of ultrasound (US)-
guided perforator injections from 1/2010-11/2012 iden-
tiﬁed 73 venous ulcers in 62 patients. Patients had no axial
reﬂux. Perforating vein identiﬁcation and closure were
assessed with US. Reﬂuxing perforators near the ulcer
were injected with polidocanol foam created in a 4:1
mixture with air. 98.4% of patients had US follow-up per-
formed 2-6 weeks after injection. Ulcers were divided into
two groups: group 1 healed ulcer(s); group 2 either healed
and recurred/never healed. All patients were treated with
compression therapy. Demographics, comorbidities, treat-
ment details and outcomes were analyzed. P # .05 was
signiﬁcant.
Results: 32 patients had healed ulcers; 30 had at least 1
non-healed ulcer. Comparisons of patients with healed vs
non-healed ulcers were: age 60.2 vs 61.3 years; male gender
50% vs 60%; history of deep vein thrombosis (DVT) 31.3%
vs 33.3% (P ¼ NS for all). Of the 73 total ulcers, 43 ulcers
were healed (group 1); 30 ulcers recurred/never healed
(group 2) for a healing rate of 59.9%. Initial ulcer size was
3.44 cm2 vs 15.1 cm2 (P ¼ NS).
189 injections were performed with a 53.8% success-
ful closure rate per injection. Successful thrombosis
occurred in 68.8% of group 1 vs 37.8% of group 2 (P
< .001). Group 1 ulcers averaged 2.2 injections per ulcer
vs 2.9 in group 2 (P ¼ .16). 24.7% of ulcers healed with
a single perforator injection. Post procedure DVTs were
seen: 5.8% of injections (11/189); four in group 1; seven
in group 2 (P ¼ NS). No other injection complications
were seen. 88.1% of group 1 ulcers had perforator
closure at the end of follow-up vs 67.8% of group 2
ulcers (P ¼ .038).
Conclusions: Successful thrombosis of pathologic
perforators with compression therapy increases ulcer heal-
ing and was found to be the only predictor of ulcer closure.Perforator closure may require multiple injections and is
associated with low DVT rates.
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Objectives: Previous studies have combined anasto-
motic, catheter-induced, and IFAA to achieve adequate
numbers for analysis, and have recommended repair of
asymptomatic IFAA with diameters $2.5 cm and all symp-
tomatic IFAA. This study evaluates the contemporary
management of IFAA, using these criteria.
Methods: Patients with IFAA were evaluated using
a standardized, prospectively maintained database by
a research consortium.
Results: From 2002-2012 236 IFAA were identiﬁed in
182 patients (mean age, 72; M:F, 16:1) at eight institutions.
Nonoperative mean diameter was 2.8 6 .7 cm; operative
diameter was 3.3 6 1.5 cm. IFAA location was: CFA
(191), SFA (34), and PFA (11). Synchronous aneurysms
(mean ¼ 1.7/patient) occurred in the aorta (181), iliac
(126), popliteal (96), hypogastric (63), mesenteric (17)
arteries, and contralateral SFA (7) and PFA (2). 66% of
repaired aneurysms were asymptomatic; other indications
included: claudication (18%), local pain (8%), nerve
compression (3%), rupture (3%), acute thrombosis (1%),
embolus (1%), and rest pain (.5%). Acute complications
(rupture, thrombosis, embolus) were associated (P < .05)
with FAA diameter >4 cm and intraluminal thrombus, but
not location. Mean diameter of symptomatic aneurysms
was: rupture, 5.7 6 1.3 cm; thrombosis, 4 6 1.1 cm; and
embolus, 3.66 .1 cm. 174 IFAAwere repairedwith interpo-
sition or bypass graft; three underwent endovascular repair.
There were two perioperative deaths at 30 days (MI,
MSOF); operative complications included wound infection
(6%), seroma (3%), and bleeding (2%). No amputations
occurred up to 5 years in either the nonoperative or operative
groups. Survivalwas: 3months¼99% (138), 1 year¼92% (n
¼ 104), and 5 years ¼ 81% (20) in operated patients.
